Complete Filing Data
Stark Focus Group, Inc. reported Net Income Loss of -$47.2 thousand for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Stark Focus Group, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Income * | -$47.2K | -$32.1K | -$49.3K | $59.5K | -$91.9K | -$8.0K |
| Operating Income Loss | -$43.2K | -$30.5K | -$48.6K | $114.3K | -$90.5K | -$8.0K |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Selling General And Administrative Expense | $54.3K | $90.5K | $11.1K | |||
| General And Administrative Expense | $43.2K | $30.5K | $36.4K | $54.3K | ||
| Revenues | $44.3K | $26.1K | ||||
| Gross Profit | $8.9K | $3.1K | ||||
| Cost Of Revenue | $35.4K | $22.9K | ||||
| Operating Expenses | $48.6K | $54.3K | ||||
| Financing Interest Expense | $4.1K | $1.6K | $705.00 | |||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | -$482.00 | ||||
| Other Nonoperating Income Expense | ||||||
| Research And Development Expense | $0.00 | $9.5K | $0.00 | |||
| Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax | -$482.00 | -$1.4K | ||||
| Income Loss From Continuing Operations | -$49.3K | $60.0K | -$90.5K | -$8.0K | ||
| Finance Lease Interest Expense | $705.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.6K | -$12.8K | -$11.0K | -$6.3K | -$9.5K | -$17.9K | -$1.7K | -$9.1K | -$14.5K | -$20.1K | -$9.0K | -$3.4K | -$10.1K | -$21.1K | -$15.1K | -$7.0K | -$18.0K | -$30.3K | -$955.00 | -$852.00 |
| Operating Income Loss | -$7.6K | -$12.8K | -$9.4K | -$6.3K | -$9.5K | -$17.4K | -$393.00 | -$389.00 | -$14.1K | -$19.8K | -$9.0K | $0.00 | -$9.2K | -$21.6K | -$14.3K | -$10.5K | -$18.0K | -$30.3K | -$955.00 | -$852.00 |
| Income Taxes Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Selling General And Administrative Expense | $9.0K | $3.4K | $11.0K | $21.6K | $14.3K | $10.5K | $20.4K | $31.2K | $955.00 | $852.00 | ||||||||||
| General And Administrative Expense | $5.6K | $11.2K | $9.4K | $5.1K | $8.5K | $17.4K | $1.3K | $8.7K | $14.1K | $7.6K | $9.0K | $3.4K | $11.0K | |||||||
| Revenues | $13.3K | $6.4K | $25.4K | $12.7K | $6.2K | $0.00 | $0.00 | |||||||||||||
| Gross Profit | $2.4K | $1.1K | $5.6K | $2.4K | $941.00 | $0.00 | $0.00 | |||||||||||||
| Cost Of Revenue | $10.8K | $5.2K | $19.8K | $10.3K | $5.3K | $0.00 | $0.00 | |||||||||||||
| Operating Expenses | $5.6K | $11.2K | $5.1K | $8.5K | $1.3K | $8.7K | $14.1K | -$19.8K | -$9.0K | $3.4K | -$11.0K | |||||||||
| Financing Interest Expense | $2.0K | $1.7K | $1.6K | $1.2K | $981.00 | $546.00 | $393.00 | $389.00 | $0.00 | $312.00 | $0.00 | |||||||||
| Income Loss From Discontinued Operations Net Of Tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$911.00 | $455.00 | ||||||||||||
| Other Nonoperating Income Expense | -$1.7K | -$981.00 | -$393.00 | -$389.00 | -$312.00 | $0.00 | ||||||||||||||
| Research And Development Expense | $9.5K | $0.00 | ||||||||||||||||||
| Discontinued Operation Amount Of Adjustment To Prior Period Gain Loss On Disposal Before Income Tax | $0.00 | -$911.00 | -$886.00 | $3.5K | ||||||||||||||||
| Income Loss From Continuing Operations | ||||||||||||||||||||
| Finance Lease Interest Expense | $385.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$61.4K | -$12.1K | -$55.8K | $36.0K | |||
| Retained Earnings Accumulated Deficit | -$136.3K | -$104.3K | -$55.0K | -$99.9K | -$8.0K | ||
| Liabilities And Stockholders Equity | $0.00 | $6.0K | $0.00 | $3.1K | $37.8K | ||
| Liabilities | $93.5K | $67.4K | $12.1K | $58.9K | $1.8K | ||
| Common Stock Value | $995.00 | $995.00 | $995.00 | $1.0K | $1.0K | ||
| Assets | $0.00 | $6.0K | $0.00 | $3.1K | $37.8K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $3.1K | ||||
| Cash And Cash Equivalents At Carrying Value | $30.3K | $0.00 | |||||
| Accounts Payable And Accrued Liabilities Current | $13.3K | $1.8K | |||||
| Cash And Cash Equivalents Period Increase Decrease | -$27.2K | $30.3K | |||||
| Accounts Payable And Other Accrued Liabilities | $0.00 | $6.0K | $6.1K | ||||
| Liabilities Current | $87.1K | $53.7K | $12.1K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | $0.00 | $0.00 | -$3.1K | -$27.2K | ||
| Convertible Notes Payable | $6.4K | $0.00 | |||||
| Long Term Notes Payable | $0.00 | $13.7K | $0.00 | ||||
| Loans Payable | $6.1K | $0.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | |||||||
| Loans Payable Current | |||||||
| Debt Current | $0.00 | $15.3K | $0.00 | ||||
| Cash Acquired From Acquisition | $0.00 | $44.3K | |||||
| Preferred Stock No Par Value | |||||||
| Cash Equivalents At Carrying Value | $3.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$172.2K | -$164.5K | -$151.7K | -$140.7K | -$111.4K | -$111.4K | -$111.4K | -$93.5K | -$86.7K | -$79.0K | -$69.9K | -$44.6K | -$24.5K | -$15.5K | $11.2K | -$92.1K | -$70.9K | -$19.2K | -$12.2K | |||||||
| Retained Earnings Accumulated Deficit | -$215.0K | -$207.4K | -$194.5K | -$183.6K | -$170.1K | -$163.7K | -$154.3K | -$129.6K | -$121.9K | -$112.7K | -$87.5K | -$67.4K | -$58.4K | -$145.4K | -$136.1K | -$115.0K | -$63.3K | -$56.3K | ||||||||
| Liabilities And Stockholders Equity | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.1K | $9.9K | $0.00 | $0.00 | $15.9K | $3.6K | $2.9K | $13.9K | $5.4K | ||||||||
| Liabilities | $172.2K | $164.5K | $151.7K | $140.7K | $127.2K | $120.9K | $111.4K | $86.7K | $79.0K | $72.0K | $54.5K | $24.5K | $15.5K | $4.8K | $95.6K | $73.8K | $33.1K | $17.6K | ||||||||
| Common Stock Value | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $995.00 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | ||||||||
| Assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $2.1K | $9.9K | $0.00 | $0.00 | $15.9K | $3.6K | $2.9K | $13.9K | $5.4K | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $15.9K | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $0.00 | $0.00 | $0.00 | $15.9K | $3.6K | $2.9K | $3.1K | $13.9K | $5.4K | $8.6K | $44.3K | $52.3K | ||||||||||||||
| Accounts Payable And Accrued Liabilities Current | $0.00 | $100.00 | $63.00 | $6.1K | $4.8K | $11.8K | $19.6K | $7.4K | $11.8K | |||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$207.00 | -$21.7K | ||||||||||||||||||||||||
| Accounts Payable And Other Accrued Liabilities | $450.00 | $4.5K | $4.5K | $2.4K | $0.00 | $0.00 | $0.00 | $0.00 | $14.1K | |||||||||||||||||
| Liabilities Current | $72.3K | $76.3K | $76.3K | $74.2K | $88.3K | $87.9K | $87.5K | $86.7K | ||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Convertible Notes Payable | $81.9K | $70.6K | $58.2K | $49.6K | $38.9K | $33.0K | $23.9K | |||||||||||||||||||
| Long Term Notes Payable | $18.0K | $17.6K | $17.2K | $16.8K | $0.00 | |||||||||||||||||||||
| Loans Payable | $57.9K | $47.7K | $41.2K | $24.4K | $15.4K | |||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $0.00 | $0.00 | ||||||||||||||||||||||||
| Loans Payable Current | $71.8K | $71.8K | $71.8K | $71.8K | $71.8K | $64.5K | $47.7K | |||||||||||||||||||
| Debt Current | $16.0K | $15.7K | $14.9K | |||||||||||||||||||||||
| Cash Acquired From Acquisition | ||||||||||||||||||||||||||
| Preferred Stock No Par Value | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Cash Equivalents At Carrying Value | $0.00 | $0.00 | $0.00 | $3.6K | $2.9K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$40.8K | -$30.5K | -$54.6K | -$64.0K | -$70.3K | -$13.7K |
| Net Cash Provided By Used In Financing Activities | $40.8K | $30.5K | $54.6K | $59.6K | $43.1K | $44.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.4K | -$6.0K | -$63.00 | -$9.2K | -$14.0K | $1.8K |
| Proceeds From Related Party Debt | $0.00 | $24.2K | $0.00 | $69.4K | $43.1K | -$1.5K |
| Increase Decrease In Prepaid Expense | $0.00 | $6.0K | $0.00 | -$7.5K | -$7.5K | |
| Proceeds From Issuance Of Common Stock | $0.00 | $1.3K | ||||
| Net Cash Provided By Used In Investing Activities | $0.00 | $1.3K | $0.00 | $0.00 | ||
| Proceeds From Convertible Debt | $40.8K | $6.4K | $0.00 | |||
| Proceeds From Sale Maturity And Collections Of Investments | $0.00 | $1.3K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q2 2018 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$7.3K | -$17.4K | -$10.6K | -$9.4K | -$11.4K | -$22.6K | |
| Net Cash Provided By Used In Financing Activities | $7.3K | $17.4K | $10.6K | $9.4K | $11.2K | $910.00 | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $2.1K | $0.00 | $0.00 | -$6.0K | -$3.8K | $127.00 | |
| Proceeds From Related Party Debt | $0.00 | $10.6K | $0.00 | $11.2K | $910.00 | ||
| Increase Decrease In Prepaid Expense | $0.00 | $3.8K | $0.00 | $0.00 | $7.5K | ||
| Proceeds From Issuance Of Common Stock | $0.00 | $0.00 | $31.00 | ||||
| Net Cash Provided By Used In Investing Activities | |||||||
| Proceeds From Convertible Debt | $7.3K | $17.4K | $0.00 | ||||
| Proceeds From Sale Maturity And Collections Of Investments |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.01 | $0.00 | ||
| Common Stock Shares Issued | 9.9M | 9.9M | 9.9M | 10.2M | 10.2M | |
| Common Stock Shares Outstanding | 9.9M | 9.9M | 9.9M | 10.2M | 10.2M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 9.9M | 9.9M | 10.2M | 4.0M | ||
| Earnings Per Shares Basic And Diluted | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | ||||||
| Shares Issued | 10.0K | |||||
| Preferred Stock Shares Outstanding | ||||||
| Preferred Stock Shares Issued | ||||||
| Preferred Stock Shares Authorized | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 9.9M | 10.2M | 10.2M | |||
| Earnings Per Share Basic | $0.00 | $0.01 | $-0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | $0.00 | -$0.01 | -$0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 | -$0.03 | $0.00 | $0.00 | |||||||
| Common Stock Shares Issued | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 10.2M | 10.2M | 10.2M | 8.0M | 200.0K | |||||
| Common Stock Shares Outstanding | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 9.9M | 10.2M | 10.2M | 10.2M | |||||||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 9.9M | 9.9M | 9.9M | 9.9M | 10.2M | 9.9M | 9.9M | 10.2M | 10.2M | 2.4M | 2.6M | ||||||||||||
| Earnings Per Shares Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.01 | $-0.01 | ||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic And Diluted | 9.9M | 9.9M | 9.9M | 10.2M | 10.2M | ||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 9.9M | 10.2M | 10.2M | 10.2M | 10.2M | 10.2M | 1.0M | ||||||||||||||||
| Shares Issued | |||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 10.2M | 10.2M | 10.2M | ||||||||||||||||||||
| Preferred Stock Shares Issued | 10.2M | 10.2M | 10.2M | ||||||||||||||||||||
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | ||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 9.9M | 9.9M | |||||||||||||||||||||
| Earnings Per Share Basic | $0.00 | $-0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid In Capital | $41.9K | $41.9K | $41.9K | $43.0K | $43.0K | |
| Due To Related Parties Current | $0.00 | $43.1K | $0.00 | |||
| Prepaid Expense Current | $0.00 | $6.0K | $0.00 | |||
| Prepaid Expense Current And Noncurrent | $0.00 | $7.5K | ||||
| Gain Or Loss On Sale Of Stock In Subsidiary | $0.00 | $1.8K | ||||
| Loans Due To Related Parties Current | $71.8K | $47.7K | ||||
| Depreciation | $0.00 | $6.0K | $0.00 | |||
| Advertising Expense | $0.00 | $2.7K | $0.00 | |||
| Amortization Of Financing Costs | ||||||
| Advance From Related Party | $41.6K | $6.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Paid Net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||
| Additional Paid In Capital | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $41.9K | $155.5K | $43.0K | $43.0K | $43.0K | $43.0K | ||
| Due To Related Parties Current | $0.00 | $83.8K | $54.3K | $25.7K | $5.8K | |||||||||||||||
| Prepaid Expense Current | $0.00 | $0.00 | $2.1K | $9.9K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||
| Prepaid Expense Current And Noncurrent | $0.00 | $0.00 | ||||||||||||||||||
| Gain Or Loss On Sale Of Stock In Subsidiary | $0.00 | $0.00 | $0.00 | $1.8K | ||||||||||||||||
| Loans Due To Related Parties Current | $71.8K | $71.8K | $71.8K | $71.8K | ||||||||||||||||
| Depreciation | ||||||||||||||||||||
| Advertising Expense | $2.7K | $0.00 | ||||||||||||||||||
| Amortization Of Financing Costs | $1.2K | $981.00 | $393.00 | $389.00 | ||||||||||||||||
| Advance From Related Party | $10.2K | $9.4K |
Most recent annual filing with the SEC: April 14, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.